Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)
INR 1805.85
(0.31%)
INR 1805.85
(0.31%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 32.73 Billion INR | -52.48% |
| 2022 | 68.89 Billion INR | 433.96% |
| 2021 | 12.9 Billion INR | -66.65% |
| 2020 | 38.68 Billion INR | -53.47% |
| 2019 | 83.14 Billion INR | -20.92% |
| 2018 | 105.14 Billion INR | 1.24% |
| 2017 | 103.85 Billion INR | 5.63% |
| 2016 | 98.31 Billion INR | 15.71% |
| 2015 | 84.96 Billion INR | -5.3% |
| 2014 | 89.72 Billion INR | 249.97% |
| 2013 | 25.63 Billion INR | 878.11% |
| 2012 | 2.62 Billion INR | -19.22% |
| 2011 | 3.24 Billion INR | -23.89% |
| 2010 | 4.26 Billion INR | 149.09% |
| 2009 | 1.71 Billion INR | -4.33% |
| 2008 | 1.78 Billion INR | 24.55% |
| 2007 | 1.43 Billion INR | -87.14% |
| 2006 | 11.16 Billion INR | -40.54% |
| 2005 | 18.78 Billion INR | 2.88% |
| 2004 | 18.25 Billion INR | 340.09% |
| 2003 | 4.14 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 20.81 Billion INR | 0.0% |
| 2023 Q2 | 19.28 Billion INR | 0.0% |
| 2023 Q4 | 32.73 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 32.73 Billion INR | -52.48% |
| 2023 Q1 | - INR | -100.0% |
| 2022 FY | 68.89 Billion INR | 433.96% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 43.69 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 68.89 Billion INR | 0.0% |
| 2021 Q4 | 12.9 Billion INR | 0.0% |
| 2021 FY | 12.9 Billion INR | -66.65% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 17.83 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 38.68 Billion INR | -53.47% |
| 2020 Q4 | 38.68 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 54.72 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 83.14 Billion INR | -20.92% |
| 2019 Q4 | 83.14 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 74.74 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 105.14 Billion INR | 1.24% |
| 2018 Q4 | 105.14 Billion INR | 0.0% |
| 2018 Q2 | 107.18 Billion INR | 0.0% |
| 2017 FY | 103.85 Billion INR | 5.63% |
| 2017 Q4 | 103.85 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 96.2 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 98.31 Billion INR | 0.0% |
| 2016 FY | 98.31 Billion INR | 15.71% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 82.95 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 70.37 Billion INR | 0.0% |
| 2015 Q4 | 84.96 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 84.96 Billion INR | -5.3% |
| 2014 Q4 | 89.72 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 3.13 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 89.72 Billion INR | 249.97% |
| 2013 FY | 25.63 Billion INR | 878.11% |
| 2013 Q4 | 25.63 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 27.04 Billion INR | 0.0% |
| 2012 FY | 2.62 Billion INR | -19.22% |
| 2012 Q4 | 2.62 Billion INR | 0.0% |
| 2012 Q2 | 2.9 Billion INR | 0.0% |
| 2011 Q4 | 3.24 Billion INR | 0.0% |
| 2011 FY | 3.24 Billion INR | -23.89% |
| 2010 FY | 4.26 Billion INR | 149.09% |
| 2009 FY | 1.71 Billion INR | -4.33% |
| 2008 FY | 1.78 Billion INR | 24.55% |
| 2007 FY | 1.43 Billion INR | -87.14% |
| 2006 FY | 11.16 Billion INR | -40.54% |
| 2005 FY | 18.78 Billion INR | 2.88% |
| 2004 FY | 18.25 Billion INR | 340.09% |
| 2003 FY | 4.14 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -9179.11% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -189315.611% |
| Sigachi Industries Limited | 1.43 Billion INR | -2188.452% |
| Bal Pharma Limited | 1.39 Billion INR | -2244.223% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -19595.276% |
| Medico Remedies Limited | 80.5 Million INR | -40564.687% |
| Lasa Supergenerics Limited | 220.76 Million INR | -14728.956% |
| Venus Remedies Limited | 413.3 Million INR | -7820.808% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -5253.508% |
| Alpa Laboratories Limited | 52.46 Million INR | -62297.217% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -415.104% |
| Shilpa Medicare Limited | 9.37 Billion INR | -249.233% |
| Aarti Drugs Limited | 5.64 Billion INR | -480.16% |
| Lupin Limited | 29.21 Billion INR | -12.044% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 50.754% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -307.072% |
| Windlas Biotech Limited | 36.41 Million INR | -89811.288% |
| Suven Life Sciences Limited | 7.09 Million INR | -461175.187% |
| Eris Lifesciences Limited | 27.81 Billion INR | -17.704% |
| Valiant Laboratories Limited | 767.08 Million INR | -4167.681% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -766.83% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -223.645% |
| Ipca Laboratories Limited | 14.38 Billion INR | -127.597% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -3178.913% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -883.603% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | -1480.167% |
| Laurus Labs Limited | 25.77 Billion INR | -27.014% |
| Piramal Pharma Limited | 47.1 Billion INR | 30.498% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -4416.242% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 18.606% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -537.943% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -165.951% |
| Unichem Laboratories Limited | 2.47 Billion INR | -1222.619% |
| Sequent Scientific Limited | 4.87 Billion INR | -571.256% |
| Novartis India Limited | 69.7 Million INR | -46868.006% |
| Wanbury Limited | 1.16 Billion INR | -2710.389% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -4936.694% |
| Wockhardt Limited | 23.56 Billion INR | -38.95% |
| Themis Medicare Limited | 957.92 Million INR | -3317.47% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -36514.137% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 10.653% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -18990.681% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | -63.52% |
| Divi's Laboratories Limited | 30 Million INR | -109022.333% |
| NATCO Pharma Limited | 3.71 Billion INR | -781.915% |
| Gufic Biosciences Limited | 3.32 Billion INR | -883.333% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -9892.888% |
| Ind-Swift Limited | 10.13 Billion INR | -222.849% |
| Procter & Gamble Health Limited | 95.6 Million INR | -34143.41% |
| FDC Limited | 205.18 Million INR | -15854.724% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -1592.436% |
| Granules India Limited | 13.15 Billion INR | -148.936% |
| Medicamen Biotech Limited | 308.17 Million INR | -10522.866% |
| Alkem Laboratories Limited | 14.18 Billion INR | -130.799% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -71094.598% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -745780.611% |
| Brooks Laboratories Limited | 56.41 Million INR | -57924.247% |
| Megasoft Limited | 1.47 Billion INR | -2126.275% |
| ZIM Laboratories Limited | 1.08 Billion INR | -2908.213% |
| Strides Pharma Science Limited | 25.16 Billion INR | -30.069% |
| Neuland Laboratories Limited | 953.89 Million INR | -3331.894% |
| Morepen Laboratories Limited | 289.99 Million INR | -11188.829% |
| Hikal Limited | 8.17 Billion INR | -300.41% |
| Indoco Remedies Limited | 6.71 Billion INR | -387.182% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -1047.649% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -10244.493% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -3223.776% |
| Hester Biosciences Limited | 2.44 Billion INR | -1239.593% |